Patent details

EP2882450 Title: FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF

Basic Information

Publication number:
EP2882450
PCT Application Number:
US2013049989
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138160312
PCT Publication Number:
WO2014011819
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AND USES THEREOF
French Title of Invention:
COMPLEXE DU FACTEUR VIII AVEC UNE SÉQUENCE XTEN ET LA PROTÉINE FACTEUR DE VON WILLEBRAND, ET UTILISATIONS ASSOCIÉES
German Title of Invention:
FAKTOR-VIII-KOMPLEX MIT XTEN UND VON-WILLEBRAND-FAKTOR-PROTEIN SOWIE VERWENDUNGEN DAVON
SPC Number:

Dates

Filing date:
10/07/2013
Grant date:
27/11/2019
EP Publication Date:
17/06/2015
PCT Publication Date:
16/01/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/11/2019
EP B1 Publication Date:
27/11/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
10/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/11/2019
 
 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, Waltham, MA 02451, United States (US)

Agent

Name:
ARONOVA S.A.
From:
20/01/2020
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
PETERS, Robert, T.
Address:
United States (US)

2

Name:
KULMAN, John
Address:
United States (US)

3

Name:
CHANG, Pei-yun
Address:
United States (US)

4

Name:
CHHABRA, Ekta, Seth
Address:
United States (US)

5

Name:
LIU, Tongyao
Address:
United States (US)

Priority

1

Priority Number:
201261670401 P
Priority Date:
11/07/2012
Priority Country:
United States (US)

2

Priority Number:
201361759819 P
Priority Date:
01/02/2013
Priority Country:
United States (US)

3

Priority Number:
201361801544 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

4

Priority Number:
201361801504 P
Priority Date:
15/03/2013
Priority Country:
United States (US)

5

Priority Number:
201361827158 P
Priority Date:
24/05/2013
Priority Country:
United States (US)

6

Priority Number:
201361840811 P
Priority Date:
28/06/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/36; A61K 38/37; C07K 14/755; C12N 15/00; C12N 15/62; C12P 21/08;

Publication

European Patent Bulletin

1

Issue number:
201948
Publication date:
27/11/2019
Description:
Grant (B1)

2

Issue number:
201952
Publication date:
25/12/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
31/07/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
25/06/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
20/01/2020 Outgoing Correspondence 1
20/01/2020 Power Of Attorney 1